Inovio Pharmaceuticals
INO
#9753
Rank
A$0.12 B
Marketcap
A$1.51
Share price
-3.64%
Change (1 day)
-31.19%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of A$0.09 Million a decrease over the revenue in the year 2024 that were of A$0.35 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A-100%
2025 A$0.09 M-72.13%
2024 A$0.35 M-71.33%
2023 A$1.22 M-91.9%
2022 A$15.08 M516.03%
2021 A$2.44 M-74.6%
2020 A$9.63 M64.11%
2019 A$5.87 M-86.43%
2018 A$43.26 M-19.99%
2017 A$54.07 M10.22%
2016 A$49.06 M-11.9%
2015 A$55.69 M335.88%
2014 A$12.77 M-15.37%
2013 A$15.09 M280.95%
2012 A$3.96 M-58.51%
2011 A$9.55 M57.92%
2010 A$6.04 M-40.42%
2009 A$10.15 M241.47%
2008 A$2.97 M-45.93%
2007 A$5.49 M24.99%
2006 A$4.39 M-41.12%
2005 A$7.47 M395.43%
2004 A$1.5 M1292.08%
2003 A$0.1 M-67.79%
2002 A$0.33 M
2000 A$9.95 M-25.66%
1999 A$13.39 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
A$137.35 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$80.64 BN/A๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$90.24 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$42.38 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$93.74 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$62.95 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
A$0.9 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$0.88 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA